Loading...

Program Description

Goals

 

  • Enhance the management of relapsed myeloma through multiple lines of therapy
  • Introduce the concept of immunotherapies in the treatment of myeloma
  • Improve the understanding of the diagnosis and treatment of MGRS

 

Objectives

 

At the end of the program participants will be able to:

 

  • Identify to select and sequence combination therapies, use rationale consideration of patient, disease, and therapy characteristics
  • Assess, risk-stratify, and treat myeloma patients using novel immune-based regimens, including CAR-T cells
  • Ascertain on how to differentiate features of various disease entities that fit under the category of MGRS and develop treatment strategies, despite the lack of data

Target Audience

 

Community health practitioners including physicians, nurses, pharmacists, trainees, and other health care providers who are involved in the care of patients with plasma cell disorders will find this program of benefit.

Program Outline

Loading...
Thank you for your interest in this program. Unfortunately, the program you have selected is currently not open for registration. Please complete a Program Inquiry so that we may promptly notify you when registration opens.
Required fields are indicated by .